Literature DB >> 12402387

Pneumatosis intestinalis associated with immune-suppressive agents in a case of minimal change disease.

Byoung Geun Han1, Jae Myoung Lee, Jae Won Yang, Min Soo Kim, Seung Ok Choi.   

Abstract

We report treatment of a 38-year-old man with minimal change disease (MCD) who developed pneumatosis intestinalis (PI) during administration of immune-suppressive agents. His immunosuppressive medication had been tapered to 15 mg/day of prednisolone. MCD was steroid-resistant type. Abdominal examination and laboratory studies were not clinically remarkable. Radiologic findings were consistent with PI. Abnormal air accumulation was noted in the bowel, peritoneum, mediastinum and retroperitoneum. Conservative therapy with oxygen and metronidazole improved the PI symptoms. In 1993, a case of PI with nephrotic syndrome following steroid treatment was reported in Japan. However this is only the second case reported in the literature, and the first in English.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402387     DOI: 10.3349/ymj.2002.43.5.686

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  3 in total

1.  Pneumatosis cystoides intestinalis in relapsing polychondritis.

Authors:  Seung-Ki Kwok; Soo-Hong Seo; Hyun-Sook Kim; Ji Hyeon Ju; Chong-Hyeon Yoon; Sung-Hwan Park; Ho-Youn Kim
Journal:  Clin Rheumatol       Date:  2006-10-18       Impact factor: 2.980

2.  Four Cases of Pneumatosis Cystoides Intestinalis Complicated by Connective Tissue Diseases.

Authors:  Eiji Suzuki; Takashi Kanno; Momoko Hazama; Hiroko Kobayashi; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Intern Med       Date:  2017-05-01       Impact factor: 1.271

3.  Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis Complicated by Pneumatosis Intestinalis.

Authors:  Saki Nakagawa; Tetsu Akimoto; Shin-Ichi Takeda; Mari Okada; Atsushi Miki; Hisashi Yamamoto; Shigeaki Muto; Eiji Kusano; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2015-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.